Luto support development of educational toolbox on medicines R & D
The European Patients’ Academy (EUPATI) today announced the launch of its new online Toolbox on Medicines Research & Development. The toolbox is available to European patient groups, patient advocates and anyone who is interested in learning more about the medicines research and development (R&D) process. It allows users to freely discover, adapt, and share materials.
The toolbox is made up of 108 topics:
These topics are addressed through 3,000 content pieces (articles, images, presentations and fact sheets).
Content is available in 7 languages (English, French, German, Spanish, Italian, Polish and Russian).
Professor Theo Raynor, Co-founder and academic advisor at Luto said, “We are excited to see this innovative collection of materials made available to the public. The vision of EUPATI to help people understand and take part in decisions about medicines is very close to that of Luto Research – where we involve members of the public in helping us to make medicines information more accessible and understandable.”
The toolbox is EUPATI’s second core product, after the Patient Expert Training Course that is now in its second cycle. The course offers a combination of e-learning and face-to-face training events to equip patients and patient advocates with information and knowledge about medicines R&D. Luto were asked to collaborate with EUPATI and offer support to the development of the materials in the training course. Luto reviewed topics to advise on readability best practice and consistency across the various materials, using our experience in information best practice and design. These materials will now form part of the toolbox.
Luto’s Project Manager commented, “EUPATI have put together some very engaging and informative content with the help of various stakeholders. It was a pleasure to be involved in reviewing the materials. The impact of both the Patient Expert Training Course and the newly released toolbox will mean that more patients around Europe can input to the development of medicines – this is incredibly important, both for patients and the wider industry.”
The European Patients’ Academy on Therapeutic Innovation provides scientifically reliable, objective, comprehensive information to patients and the general public on the research and development process of medicines. You can access the ‘EUPATI Toolbox on Medicines R&D’ in 7 languages at www.eupati.eu.
Contact us today to find out more about how we can help you to make health information more accessible.